|
Volumn 108, Issue 2, 2001, Pages 331-337
|
Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery
a b b c b
c
New Orleans
*
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
KETOROLAC TROMETAMOL;
PLACEBO;
ARTICLE;
CATARACT EXTRACTION;
CILIARY BODY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
EYE INFECTION;
FEMALE;
HUMAN;
INTRAOCULAR PRESSURE;
LENS IMPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PHOTOPHOBIA;
POSTOPERATIVE COMPLICATION;
POSTOPERATIVE INFECTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
TREATMENT OUTCOME;
VISUAL ACUITY;
ADMINISTRATION, TOPICAL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTERIOR CHAMBER;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
INFLAMMATION;
INTRAOCULAR PRESSURE;
KETOROLAC TROMETHAMINE;
LENS IMPLANTATION, INTRAOCULAR;
MALE;
MIDDLE AGED;
OPHTHALMIC SOLUTIONS;
PHACOEMULSIFICATION;
PROSPECTIVE STUDIES;
SAFETY;
UVEITIS, ANTERIOR;
VISUAL ACUITY;
|
EID: 0035153649
PISSN: 01616420
EISSN: None
Source Type: Journal
DOI: 10.1016/S0161-6420(00)00543-1 Document Type: Article |
Times cited : (70)
|
References (18)
|